Clinical Trials List
2022-12-01 - 2025-02-26
Phase II
Recruiting5
ICD-10I97.3
Postprocedural hypertension
ICD-9997.91
Complications affecting other specified body system, not elsewhere classified, hypertension
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsung-Lin Yang Division of Cardiovascular Diseases
- 陳志維 Division of Cardiovascular Diseases
- Wei-Fung Bi Division of Cardiovascular Diseases
- 徐千彞 Division of Cardiovascular Diseases
- 詹超舜 Division of Cardiovascular Diseases
- 蕭成儀 Division of Cardiovascular Diseases
- 鄭宇倫 Division of Cardiovascular Diseases
- Yung-Ta Kao Division of Cardiovascular Diseases
- 蕭卜源 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃偉杰 Division of Cardiovascular Diseases
- Wen-Chung Yu Division of Cardiovascular Diseases
- Chen-Huan Chen Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
- Shih-Lin Chang Division of Cardiovascular Diseases
- 王維庭 Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HUNG-JU LIN Division of Cardiovascular Diseases
- 鄭人方 Division of Cardiovascular Diseases
- 賀立婷 Division of Cardiovascular Diseases
- 林柏志 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 卓士傑 Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
170 participants